Effect of magnesium hydroxide on iron absorption following simulated mild iron overdose in human subjects

Academic Emergency Medicine

Volumn 5, Issue 10, 1998, Pages 961-965

  Wallace, Kevin L ^a,b   Curry, Steven C ^a   Lovecchio, Frank ^a   Raschke, Robert A ^a  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b Department of Medical Toxicology ^*  (United States)

Author keywords

Absorption; Iron; Magnesium oxide; Overdose; Poisoning

Indexed keywords

DEFEROXAMINE; HYDROGEN PEROXIDE; IRON; MAGNESIUM HYDROXIDE; MAGNESIUM OXIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HUMAN; HUMAN EXPERIMENT; IRON ABSORPTION; IRON BLOOD LEVEL; IRON OVERLOAD; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE ABSORPTION;

EID: 0031692297     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.1998.tb02771.x     Document Type: Article

References (12)

1. Dean BS, Krenzelok EP. In vivo effectiveness of oral complexation agents in the management of iron poisoning. Clin Toxicol. 1987; 25:221-30.
2. Dean BS, Oehme FW, Krenzelok EP, Griffith GR, Hines RH. Iron complexation with oral deferoxamine in a swine model. Vet Hum Toxicol. 1996; 38(2):96-8.
3. Decker WJ, Shafik HM, Corby DG, Hilburn RE. Sequestration of iron by magnesium oxide: an in vitro study. Vet Hum Toxicol. 1981; 23(suppl 1):33-4.
4. Corby DG, McCullen AH, Chadwick EW. Effect of orally administered magnesium hydroxide in experimental iron intoxication. Clin Toxicol. 1985-86; 23(7&8):489-99.
5. Walker SE, Paton TW, Cowan DH, Manuel MA, Dranitsaris G. Bioavailability of iron in oral ferrous sulfate preparations in healthy volunteers. Can Med Assoc J. 1989; 141:543-7.
6. Chiou WL. Ferrous sulfate bioavariability monograph. J Am Pharm Assoc. 1977; 17:377-80.
7. Jackson TW, Ling LJ, Washington V. The effect of oral deferoxamine on iron absorption in humans. Clin Toxicol. 1995; 33(4):325-9.
8. Gomez HF, McClafferty HH, Flory D, Brent J, Dart RC. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry. Ann Emerg Med. 1997; 30:587-92.
9. Mills KC, Curry SC. Acute iron poisoning. Emerg Med Clin North Am. 1994; 12:397-413.
10. Jones J, Heiselman D, Dougherty J, Eddy A. Cathartic-induced magnesium toxicity during overdose management. Ann Emerg Med. 1986; 15:1214-8.
11. Smilkstein MJ, Smolinske SC, Kulig KW, Rumack BH. Severe hypermagnesemia due to multiple-dose cathartic therapy. West J Med. 1988; 148:208-11.
12. Smilkstein MJ, Steedle D, Kulig KW, Marx JA, Rumack BH. Magnesium levels after magnesium-containing cathartics. Clin Toxicol. 1988; 26(1&2):51-64.